A convolutional neural network-based model that predicts acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

[1]  J. Kanda,et al.  Establishment of a predictive model for GVHD-free, relapse-free survival after allogeneic HSCT using ensemble learning , 2021, Blood advances.

[2]  Yoshinobu Kanda,et al.  Using a machine learning algorithm to predict acute graft-versus-host disease following allogeneic transplantation. , 2019, Blood advances.

[3]  Amy C. Dwyer,et al.  A Novel CNN-Based CAD System for Early Assessment of Transplanted Kidney Dysfunction , 2019, Scientific Reports.

[4]  James M. Rondinelli,et al.  Theory-Guided Machine Learning in Materials Science , 2016, Front. Mater..

[5]  Carlos Guestrin,et al.  "Why Should I Trust You?": Explaining the Predictions of Any Classifier , 2016, ArXiv.

[6]  Y. Kanda,et al.  Clinical significance of high-dose cytarabine added to cyclophosphamide/total-body irradiation in bone marrow or peripheral blood stem cell transplantation for myeloid malignancy , 2015, Journal of Hematology & Oncology.

[7]  C. Nakaseko,et al.  Efficiency of high-dose cytarabine added to CY/TBI in cord blood transplantation for myeloid malignancy. , 2015, Blood.

[8]  M. Robin,et al.  A refined risk score for acute graft-versus-host disease that predicts response to initial therapy, survival, and transplant-related mortality. , 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[9]  Tomohiro Watanabe,et al.  Serum neutrophil extracellular trap levels predict thrombotic microangiopathy after allogeneic stem cell transplantation. , 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[10]  S. Iacobelli.  Suggestions on the use of statistical methodologies in studies of the European Group for Blood and Marrow Transplantation , 2013, Bone Marrow Transplantation.

[11]  J. Ritz,et al.  Use of matched unrelated donors compared with matched related donors is associated with lower relapse and superior progression-free survival after reduced-intensity conditioning hematopoietic stem cell transplantation. , 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[12]  R. Storb,et al.  Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria. , 2011, Blood.

[13]  B. Sandmaier,et al.  Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[14]  Harriet Noreen,et al.  High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. , 2007, Blood.

[15]  M. Sorror,et al.  Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. , 2005, Blood.

[16]  J. Wagner,et al.  Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: comparison of grading systems. , 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[17]  Robert Gray,et al.  A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .

[18]  E. McFadden,et al.  Toxicity and response criteria of the Eastern Cooperative Oncology Group , 1982, American journal of clinical oncology.

[19]  H. Nakasone,et al.  Risk factors and prognosis of hepatic acute GvHD after allogeneic hematopoietic cell transplantation , 2016, Bone Marrow Transplantation.

[20]  Y. Atsuta.  Introduction of Transplant Registry Unified Management Program 2 (TRUMP2): scripts for TRUMP data analyses, part I (variables other than HLA-related data) , 2015, International Journal of Hematology.

[21]  R. Gray.  A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk , 1988 .